BeiGene Ltd. ADR’s filing revealed that its Chair, Scientific Advisory Brd Wang Xiaodong unloaded Company’s shares for reported $10.91 million on Mar 18 ’25. In the deal valued at $261.28 per share,41,760 shares were sold. As a result of this transaction, Wang Xiaodong now holds 0 shares worth roughly $0.0.
Then, OYLER JOHN sold 41,210 shares, generating $10,000,483 in total proceeds. Upon selling the shares at $242.67, the Chief Executive Officer now owns 0 shares.
Before that, JOHN OYLER bought 41,210 shares. BeiGene Ltd. ADR shares valued at $10,000,480 were divested by the Officer at a price of $242.67 per share.
BofA Securities upgraded its BeiGene Ltd. ADR [ONC] rating to a Buy from a a Neutral in a research note published on March 03, 2025; the price target was increased to $320 from $207. JMP Securities began covering ONC with “Mkt outperform” recommendation on September 18, 2024.
Price Performance Review of ONC
On Monday, BeiGene Ltd. ADR [NASDAQ:ONC] saw its stock jump 1.79% to $272.17. Over the last five days, the stock has gained 7.49%. BeiGene Ltd. ADR shares have risen nearly 47.35% since the year began. Nevertheless, the stocks have risen 75.50% over the past one year. While a 52-week high of $287.88 was reached on 02/27/25, a 52-week low of $126.97 was recorded on 01/08/25. SMA at 50 days reached $243.19, while 200 days put it at $202.43.
Levels Of Support And Resistance For ONC Stock
The 24-hour chart illustrates a support level at 265.98, which if violated will result in even more drops to 259.80. On the upside, there is a resistance level at 276.80. A further resistance level may holdings at 281.44. The Relative Strength Index (RSI) on the 14-day chart is 63.17, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 8.27, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 9.88%. Stochastics %K at 81.51% indicates the stock is a selling.
How much short interest is there in BeiGene Ltd. ADR?
A steep rise in short interest was recorded in BeiGene Ltd. ADR stocks on 2025-03-14, growing by 0.17 million shares to a total of 1.64 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-14 was 1.48 million shares. There was a rise of 10.07%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on September 12, 2023 when Macquarie began covering the stock and recommended ‘”an Outperform”‘ rating along with a $259 price target.
